GLP-1 drugs like Ozempic may lower obesity-related cancer risks, although no direct correlation has been confirmed.
People with type 2 diabetes who used glucagon-like peptide analogs such as Ozempic or Mounjaro had a lower risk for multiple ...
GLP-1 medications such as Ozempic may help lower the risk of certain cancers. GLP-1 medications such as Ozempic and Wegovy ...
More evidence suggests that medications such as Ozempic and Mounjaro, originally developed for diabetes and then approved for ...
GLP-1 drugs, like Ozempic and Wegovy have been associated with a lower risk of cancer in diabetics according to a new study.
Obesity increases the risk of developing a number of cancers, so it stands to reason that drugs that reduce body weight ...
The study is the latest evidence to suggest that widely popular diabetes and weight-loss shots may have a role in cancer prevention.
People taking diabetes drugs such as GLP-1RAs saw a significant reduction in their risk of 10 out of 13 obesity-associated ...
Research shows drugs like Ozempic and Wegovy could reduce the risk of cancer, along with helping people lose weight. Dr. Christopher DuCoin, director of TGH’s Digestive Diseases Institute, joined FOX ...
A report is trending suggesting that weight loss medications like Ozempic can lower the risk of cancers linked to obesity. Here, with a look at the science behind the study and answering the ...
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a ...
Students at Weill Cornell Medicine-Qatar (WCM-Q) have made a significant contribution to the field by publishing a study that ...